• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Theses
  • Research Data
  • Projects
  • Organizations
  • Researchers
  • More
  • Collections
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. p62/SQSTM1 upregulation constitutes a survival mechanism that occurs during granulocytic differentiation of acute myeloid leukemia cells.
 

p62/SQSTM1 upregulation constitutes a survival mechanism that occurs during granulocytic differentiation of acute myeloid leukemia cells.

Options
  • Details
Publisher DOI
10.1038/cdd.2014.102
PubMed ID
25034783
Description
The p62/SQSTM1 adapter protein has an important role in the regulation of several key signaling pathways and helps transport ubiquitinated proteins to the autophagosomes and proteasome for degradation. Here, we investigate the regulation and roles of p62/SQSTM1 during acute myeloid leukemia (AML) cell maturation into granulocytes. Levels of p62/SQSTM1 mRNA and protein were both significantly increased during all-trans retinoic acid (ATRA)-induced differentiation of AML cells through a mechanism that depends on NF-κB activation. We show that this response constitutes a survival mechanism that prolongs the life span of mature AML cells and mitigates the effects of accumulation of aggregated proteins that occurs during granulocytic differentiation. Interestingly, ATRA-induced p62/SQSTM1 upregulation was impaired in maturation-resistant AML cells but was reactivated when differentiation was restored in these cells. Primary blast cells of AML patients and CD34(+) progenitors exhibited significantly lower p62/SQSTM1 mRNA levels than did mature granulocytes from healthy donors. Our results demonstrate that p62/SQSTM1 expression is upregulated in mature compared with immature myeloid cells and reveal a pro-survival function of the NF-κB/SQSTM1 signaling axis during granulocytic differentiation of AML cells. These findings may help our understanding of neutrophil/granulocyte development and will guide the development of novel therapeutic strategies for refractory and relapsed AML patients with previous exposure to ATRA.
Date of Publication
2014-12
Publication Type
Article
Language(s)
en
Contributor(s)
Trocoli, A
Bensadoun, P
Richard, E
Labrunie, G
Merhi, F
Bill, Anna Magdalena
Department for BioMedical Research, Zentrale Dienste Betrieb
Brigger, Daniel
Departement Klinische Forschung, Forschungsgruppe Med. Onkologie / Hämatologie (Erw.)
Souquere, S
Pierron, G
Pasquet, J-M
Soubeyran, P
Reiffers, J
Ségal-Bendirdjian, E
Tschan, Marioorcid-logo
Departement Klinische Forschung, Forschungsgruppe Med. Onkologie / Hämatologie (Erw.)
Djavaheri-Mergny, M
Additional Credits
Departement Klinische Forschung, Forschungsgruppe Med. Onkologie / Hämatologie (Erw.)
Department for BioMedical Research, Zentrale Dienste Betrieb
Series
Cell death and differentiation
Publisher
Nature Publishing Group
ISSN
1350-9047
Access(Rights)
metadata.only
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: dd892c [ 9.04. 8:30]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
  • Events
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo